NEW YORK (GenomeWeb) – The Australian Genomic Cancer Medicine Program has won A$50 million ($36.6 million) in funding from the Australian government, the Garvan Institute of Medical Research said yesterday.
The program, developed at the Garvan Institute, matches patients with rare and uncommon cancers to therapies based on their genome information. Originally funded with A$7 million from the New South Wales government, the program has served more than 1,000 patients since 2016.
To read the full story….
…and receive Daily News bulletins.
Already have an account?